Adarza Biosystems this week appointed Heiner Dreismann and James Senall to its board of directors.
Dreismann was previously the CEO of Roche Molecular Systems and held several senior positions at Roche Diagnostics before that.
Senall is the president of High Tech Rochester, an Adarza shareholder, and is director of the Rochester Angel Network. Previously, he was managing director of business development at Greater Rochester Enterprise.
ACS Biomarker this week named Heico Breek as its CEO.
Previously, he was CEO of cardiovascular testing company Cavadis, as well as chief commercial officer at TiGenix and a general manager at Aventis.
Venture capitalist Peter Thiel this week announced the appointment of 24 Thiel fellows, each of whom will receive $100,000 over two years to pursue innovative scientific and technical projects. Among the awardees is Alexander Kiselev, whose project is to develop an inexpensive HPLC system.